!??
Depends what “this” includes alongside GLP-1 therapy.
Combination approaches sometimes outperform single pathway targeting
Insulin sensitivity influenced by muscle mass changes too.
Diet quality still drives majority improvements honestly.
Sleep and stress management amplify pharmacological benefits.
Multi-agonists may enhance glucose disposal mechanisms.
Monitor fasting insulin not just glucose numbers.
Body composition shifts strongly affect sensitivity outcomes.
Some stacks improve hepatic and peripheral sensitivity.
Bloodwork comparisons best determine actual effectiveness.
